Precision Cardiology Sweden - a Strategic AI & Biotech cluster aiming to eradicate cardiovascular disease
| Reference number | |
| Coordinator | Göteborgs universitet - Sahlgrenska akademin Wallenberglaboratoriet |
| Funding from Vinnova | SEK 1 321 708 |
| Project duration | October 2025 - March 2026 |
| Status | Ongoing |
| Venture | Cluster of Excellence for Cutting-Edge Technologies - calls for proposals |
| Call | Visions for world-leading research and innovation in strategic technology areas |
Purpose and goal
Our vision is that by 2035, Sweden will be a world leader in precision cardiology, achieving the best possible heart health. The cluster will use advanced health data to drive breakthroughs in AI and biotechnology. By integrating data from registries, biobanks, omics, and imaging, we will enable early risk assessment and more precise cardiovascular care.
Expected effects and result
A clearly defined vision A robust consortium consisting of industry, academia, the public sector, and civil society, with the competence and capacity needed to realize the vision A plan to use existing data from registries, patient cohorts, and biobanks to train privacy-preserving generative simulators that produce multidimensional synthetic datasets which cannot be linked to individual persons Relevant target groups are aware of the vision
Planned approach and implementation
The project will be carried out in four parts: 1) formulate and anchor a joint vision and roadmap for precision cardiology 2035, 2) build a strong consortium across healthcare, academia, industry, and the public sector, 3) develop a plan to use existing data and create privacy-preserving AI simulators, and 4) communicate the vision and visualize the cluster’s potential.